Career history of David J. Valacer
Former positions of David J. Valacer
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Chief Tech/Sci/R&D Officer | 2017-07-31 | 2017-10-19 |
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
Training of David J. Valacer
| New York University | Graduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
- Stock Market
- Insiders
- David J. Valacer
- Experience
